Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.01 (0.02%)
Data as of 07/28/17 2:36 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $41.29 with a 52 week high of $44.70 and a 52 week low of $22.16.
Recent News
07/19/17iRhythm Technologies to Report Second Quarter 2017 Financial Results on August 2, 2017Printer Friendly Version
07/19/17iRhythm Technologies Names Former Blue Cross Blue Shield of California CEO Bruce G. Bodaken and Duke University Chancellor Emeritus Ralph Snyderman, M.D. to its Board of Directors Printer Friendly Version
07/10/17Research Collaboration Demonstrates Use of Deep Learning to Develop Expert Level Comprehensive Cardiac Arrhythmia Detection AlgorithmPrinter Friendly Version
Upcoming Events
08/02/17 1:30 p.m. PT
iRhythm Technologies Inc Q2 2017 Earnings Conference Call